ArticleMalaria journal2025
Access and usage of malaria control measures by women of reproductive age in Mopeia Mozambique.
Article in Malaria journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMalaria presents a disproportionate threat to pregnant women, making access to malaria prevention tools crucial for controlling the disease in this vulnerable population.
methodsThis prospective descriptive study targeted women of reproductive age (13-49 years old) living in the Mopeia district, a high malaria endemic area in Zambezia province, Mozambique. As part of the BOHEMIA cluster randomized trial, the study included a simplified and full census to collect data on socio-demographic, socio-economic and household factors, health status, and malaria prevention tools from the target population.
resultsData from 7,099 women of reproductive age living in the BOHEMIA clinical trial study area was collected, including 497 (7.0%) self-referred as pregnant. Access to malaria vector control tools was high, with 89.9% of women self-referred as pregnant, 87.9% of women self-referred as not- pregnant living in a household with at least one long-lasting insecticidal net and 69.6% of women self-referred as pregnant and 73.4% of women self-referred as not-pregnant living in household that received indoor residual spraying in the past 12 months. Intermittent preventive treatment coverage was moderate-low, with 53.1% of women self-reported as pregnant having taken at least one dose.
conclusionsThis study found that women of reproductive age in the highly-endemic Mopeia district have good access to malaria vector control tools. However, intermittent preventive treatment coverage remains below World Health Organization-recommended levels. Focused efforts are needed to improve this coverage, and continuous monitoring along with tailored interventions are essential for achieving optimal prevention outcomes among vulnerable populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.